Rousseau A - Search Results

1

Adaptive control methods for the dose individualisation of anticancer agents.

Rousseau A, Marquet P, Debord J, Sabot C, Lachâtre G. Rousseau A, et al. Clin Pharmacokinet. 2000 Apr;38(4):315-53. doi: 10.2165/00003088-200038040-00003. Clin Pharmacokinet. 2000. PMID: 10803455 Review.

2

Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants.

Leger F, Debord J, Le Meur Y, Rousseau A, Büchler M, Lachâtre G, Paintaud G, Marquet P. Leger F, et al. Among authors: rousseau a. Clin Pharmacokinet. 2002;41(1):71-80. doi: 10.2165/00003088-200241010-00006. Clin Pharmacokinet. 2002. PMID: 11825098 Clinical Trial.

3

Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcoma.

Rousseau A, Sabot C, Delepine N, Delepine G, Debord J, Lachâtre G, Marquet P. Rousseau A, et al. Clin Pharmacokinet. 2002;41(13):1095-104. doi: 10.2165/00003088-200241130-00006. Clin Pharmacokinet. 2002. PMID: 12403645 Clinical Trial.

4

Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs.

Rousseau A, Marquet P. Rousseau A, et al. Fundam Clin Pharmacol. 2002 Aug;16(4):253-62. doi: 10.1046/j.1472-8206.2002.00086.x. Fundam Clin Pharmacol. 2002. PMID: 12570013 Review.

5

Modelling ciclosporin double-peak absorption profiles in the early post-transplantation period.

Rousseau A, Marquet P. Rousseau A, et al. Clin Pharmacokinet. 2004;43(14):1055-7. doi: 10.2165/00003088-200443140-00007. Clin Pharmacokinet. 2004. PMID: 15530133

6

A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetil.

Prémaud A, Debord J, Rousseau A, Le Meur Y, Toupance O, Lebranchu Y, Hoizey G, Le Guellec C, Marquet P. Prémaud A, et al. Among authors: rousseau a. Clin Pharmacokinet. 2005;44(8):837-47. doi: 10.2165/00003088-200544080-00005. Clin Pharmacokinet. 2005. PMID: 16029068 Clinical Trial.

7

Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies.

Saint-Marcoux F, Knoop C, Debord J, Thiry P, Rousseau A, Estenne M, Marquet P. Saint-Marcoux F, et al. Among authors: rousseau a. Clin Pharmacokinet. 2005;44(12):1317-28. doi: 10.2165/00003088-200544120-00010. Clin Pharmacokinet. 2005. PMID: 16372829 Clinical Trial.

8

Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients.

Saint-Marcoux F, Marquet P, Jacqz-Aigrain E, Bernard N, Thiry P, Le Meur Y, Rousseau A. Saint-Marcoux F, et al. Among authors: rousseau a. Clin Pharmacokinet. 2006;45(9):905-22. doi: 10.2165/00003088-200645090-00003. Clin Pharmacokinet. 2006. PMID: 16928152

9

Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.

Djebli N, Rousseau A, Hoizey G, Rerolle JP, Toupance O, Le Meur Y, Marquet P. Djebli N, et al. Among authors: rousseau a. Clin Pharmacokinet. 2006;45(11):1135-48. doi: 10.2165/00003088-200645110-00007. Clin Pharmacokinet. 2006. PMID: 17048977

10

[Pharmacokinetics and therapeutic drug monitoring of anticancer agents].

Marquet P, Rousseau A. Marquet P, et al. Among authors: rousseau a. Bull Cancer. 2008 Oct;95(10):903-9. doi: 10.1684/bdc.2008.0725. Bull Cancer. 2008. PMID: 19004719 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,074 results

Search Page

Filters